M&A Deal Summary

Abzena Acquires The Chemistry Research Solution

On December 11, 2015, Abzena acquired life science company The Chemistry Research Solution

Acquisition Highlights
  • This is Abzena’s 1st transaction in the Life Science sector.
  • This is Abzena’s 2nd transaction in the United States.
  • This is Abzena’s 1st transaction in Pennsylvania.

M&A Deal Summary

Date 2015-12-11
Target The Chemistry Research Solution
Sector Life Science
Buyer(s) Abzena
Deal Type Add-on Acquisition

Target

The Chemistry Research Solution

Bristol, Pennsylvania, United States
The Chemistry Research Solution LLC is a contract chemistry and bioconjugation business focused on antibody drug conjugates (ADCs).

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Abzena

Cambridge, United Kingdom

Category Company
Sector Life Science
Employees180
Revenue 10M GBP (2016)
DESCRIPTION

Abzena is a life science company, that provides proprietary technologies and value-added services to enable the development of better biopharmaceuticals. Abzena comprises two wholly owned subsidiary businesses – PolyTherics and Antitope. Abzena is based in Cambridge, United Kingdom.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
State: Pennsylvania M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2015 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-14 PacificGMP

San Diego, California, United States

PacificGMP, Inc. is a producer of recombinant proteins, antibodies, cell therapies and vaccines for preclinical and clinical materials.

Buy $8M